Renal replacement therapies for acute renal failure: does dose matter?
Tolwani
Ashita
A
University of Alabama, Birmingham, AL, USA. atolwani@uab.edu
D000328:Adult; D000818:Animals; D003422:Critical Care / Q000379:methods; D004630:Emergencies; D006440:Hemofiltration; D006801:Humans; D007683:Kidney Tubular Necrosis, Acute / Q000209:etiology / Q000628:therapy*; D008297:Male; D015337:Multicenter Studies as Topic; D010727:Phosphoric Diester Hydrolases / Q000009:adverse effects; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D006435:Renal Dialysis; D017582:Renal Replacement Therapy / Q000379:methods*; D001098:Spider Bites / Q000150:complications*; D013111:Spider Venoms / Q000009:adverse effects; D013112:Spiders; D015996:Survival Rate; D014508:Urea / Q000097:blood
D013111:Spider Venoms; C055161:loxosceles venom; D014508:Urea; D010727:Phosphoric Diester Hydrolases